Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Oligomerix continues NIH-funded work on tau oligomer inhibitor

June 4, 2019

Polish researchers identify 5-HT6 receptor antagonists

June 4, 2019

Kissei Pharmaceutical describes CGRP receptor antagonists

June 4, 2019

Fragile X quick-ish fix?

June 3, 2019

Patient enrollment ongoing in phase I study of BIIB-100

June 3, 2019

Promising phase II efficacy data presented for NRX-101

May 31, 2019

Michael J. Fox Foundation awards Casma Therapeutics grant to advance PD drug development

May 30, 2019

Xeomin approved in E.U. for treatment of chronic sialorrhea in adults

May 30, 2019

Gut-derived live bacterial strains found to modulate neuroinflammation and neurodegeneration in PD

May 30, 2019

Expansion Therapeutics initiates phase I trial of ERX-963 in adults with DM1

May 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...